NPCE NEUROPACE INC revenue, earnings and financials
For the quarter ended June 30, 2026, NEUROPACE INC reported revenue of $22.8M (up 17.1% from a year earlier), net income of −$6.20M and diluted EPS of −$0.18; over the last four quarters revenue was $103M and net income −$19.1M; for the fiscal year ended December 2025 revenue was $100.0M, up 25.1% on the year before.
NPCE annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $100.0M, gross profit $77.2M, operating income −$16.3M, net income −$21.5M (margin -21.5%), EPS −$0.66
- Fiscal year ended Dec 2024: revenue $79.9M, gross profit $59.1M, operating income −$21.7M, net income −$27.1M (margin -34.0%), EPS −$0.93
- Fiscal year ended Dec 2023: revenue $65.4M, gross profit $48.1M, operating income −$27.2M, net income −$33.0M (margin -50.4%), EPS −$1.27
- Fiscal year ended Dec 2022: revenue $45.5M, gross profit $32.5M, operating income −$40.8M, net income −$47.1M (margin -103.4%), EPS −$1.91
- Fiscal year ended Dec 2021: revenue $45.2M, gross profit $33.4M, operating income −$23.7M, net income −$36.1M (margin -79.9%), EPS −$2.17
NPCE quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $22.8M (up 17.1% year over year), net income −$6.20M, EPS −$0.18
- Quarter ended Mar 31, 2026: revenue $22.1M (down 2.0% year over year), net income −$6.69M, EPS −$0.20
- Quarter ended Dec 31, 2025 (from the annual report): revenue $30.6M (up 42.6% year over year), net income −$2.73M, EPS −$0.08
- Quarter ended Sep 30, 2025: revenue $27.4M (up 29.9% year over year), net income −$3.50M, EPS −$0.11
- Quarter ended Jun 30, 2025: revenue $19.5M (up 1.3% year over year), net income −$8.65M, EPS −$0.26
- Quarter ended Mar 31, 2025: revenue $22.5M (up 24.3% year over year), net income −$6.59M, EPS −$0.21
- Quarter ended Dec 31, 2024 (from the annual report): revenue $21.5M (up 19.2% year over year), net income −$5.25M, EPS −$0.16
- Quarter ended Sep 30, 2024: revenue $21.1M (up 28.2% year over year), net income −$5.45M, EPS −$0.19
- Quarter ended Jun 30, 2024: revenue $19.3M (up 16.6% year over year), net income −$7.51M, EPS −$0.26
- Quarter ended Mar 31, 2024: revenue $18.1M (up 25.2% year over year), net income −$8.93M, EPS −$0.32
- Quarter ended Dec 31, 2023 (from the annual report): revenue $18.0M (up 40.8% year over year), net income −$6.20M, EPS −$0.22
- Quarter ended Sep 30, 2023: revenue $16.4M (up 47.2% year over year), net income −$7.26M, EPS −$0.28
- Quarter ended Jun 30, 2023: revenue $16.5M (up 61.9% year over year), net income −$9.12M, EPS −$0.36
- Quarter ended Mar 31, 2023: revenue $14.5M (up 27.2% year over year), net income −$10.4M, EPS −$0.41
- Quarter ended Dec 31, 2022 (from the annual report): revenue $12.8M (up 16.3% year over year), net income −$11.1M, EPS −$0.44
- Quarter ended Sep 30, 2022: revenue $11.2M (up 7.9% year over year), net income −$11.8M, EPS −$0.48
- Quarter ended Jun 30, 2022: revenue $10.2M (down 19.2% year over year), net income −$12.7M, EPS −$0.52
- Quarter ended Mar 31, 2022: revenue $11.4M (up 1.4% year over year), net income −$11.5M, EPS −$0.47
- Quarter ended Dec 31, 2021 (from the annual report): revenue $11.0M, net income −$10.7M, EPS $31.38
- Quarter ended Sep 30, 2021: revenue $10.3M, net income −$8.08M, EPS −$0.34
NPCE cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$11.0M, share buybacks $49.5M, dividends $0.00 per share
- Fiscal year ended Dec 2024: operating cash flow −$17.9M, share buybacks $0, dividends $0.00 per share
- Fiscal year ended Dec 2023: operating cash flow −$19.7M, share buybacks n/a, dividends $0.00 per share
- Fiscal year ended Dec 2022: operating cash flow −$36.9M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$24.6M, share buybacks n/a
NPCE balance sheet
- Jun 30, 2026: cash $12.5M, total assets $97.0M, total liabilities $85.1M, shareholders' equity $11.9M, long-term debt $59.0M
- Mar 31, 2026: cash $14.8M, total assets $98.9M, total liabilities $84.4M, shareholders' equity $14.5M, long-term debt $59.0M
- Dec 31, 2025: cash $21.7M, total assets $106M, total liabilities $86.5M, shareholders' equity $19.0M, long-term debt $58.9M
- Sep 30, 2025: cash $20.6M, total assets $107M, total liabilities $88.7M, shareholders' equity $18.5M, long-term debt $58.7M
- Jun 30, 2025: cash $22.9M, total assets $106M, total liabilities $86.7M, shareholders' equity $19.4M, long-term debt $58.6M
- Mar 31, 2025: cash $27.0M, total assets $110M, total liabilities $85.9M, shareholders' equity $24.3M, long-term debt $59.8M
- Dec 31, 2024: cash $13.4M, total assets $94.6M, total liabilities $86.6M, shareholders' equity $8.01M, long-term debt $59.5M
- Sep 30, 2024: cash $15.4M, total assets $96.3M, total liabilities $86.5M, shareholders' equity $9.82M, long-term debt $59.3M
What is NPCE's revenue?
NEUROPACE INC reported $103M of revenue over its last four quarters, through June 30, 2026.
Is NPCE profitable?
No. NEUROPACE INC lost $19.1M over the last four quarters.
What is NPCE's EPS?
Diluted earnings per share over the last four quarters were −$0.57; −$0.18 in the latest quarter.